Kneeland Youngblood is a co-founder of Pharos Capital Group and serves as Chairman and CEO from the firm’s Dallas office. See contact routes.
Kneeland Youngblood is a co-founder of Pharos Capital Group and serves as Chairman and CEO from the firm’s Dallas office, where he oversees firm strategy, sits on investment committees, and works across portfolio companies. Pharos was founded in 1998 and later narrowed its focus to healthcare investing in the United States, especially companies aimed at reducing disparities in care and improving access and outcomes in underserved communities. The firm targets established, U.S.-based healthcare businesses and invests primarily in later-stage growth, acquisitions, and recapitalizations. Pharos publicly states an investment size of $25 million to $50 million per platform company, with no minimums for add-ons, which indicates it typically leads platform investments rather than small minority checks. Named portfolio companies mentioned in available sources include Reel FX, and broader Pharos portfolio references also cite firms such as Seaside Healthcare, Complete Health, Medfinders, MCCI Medical Management, and Charter Health. Youngblood’s public point of view is consistent with a patient-centric healthcare thesis focused on lowering costs, improving outc
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Dallas.
Investors like Kneeland Youngblood · Full investor directory · Investor access · Company funding database